Search Results 311-320 of 1911 for 搜索引擎平台开发咨询邮箱:lgooxc@hotmail.com
Eligibility: - People who are documented exceptional responders to cancer treatment. They must have given a tumor sample that is available to researchers.
About this study. The purpose of this study is to collect data to try to identify biomarkers that have the potential to personalize asthma therapeutic ...
Dr. Cerhan's team in the Lymphoma Epidemiology Lab at Mayo Clinic has expertise in cancer epidemiology, hematology, immunology, laboratory medicine and ...
See the application selection process for Benefactor-Funded Research Early-Career Development Awards at Mayo Clinic's Center for Clinical and Translational ...
Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving ixabepilone together with temsirolimus may kill ...
Drugs used in chemotherapy, such as AFP464, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The primary purpose of this study is to evaluate the incremental invasive cancer yield in patients with a negative mammogram who are ...
Mayo Clinic Center for Clinical and Translational Science logo. Accelerating innovative medical research to improve patient care and health for all people. Mayo ...
Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.